Certolizumab for repeated embryo transfer pregnancy failure
Treatments studied
Part of Immune system & allergy, Women’s health & pregnancy clinical trials.
This Phase 3 study tests certolizumab to help people with repeated embryo transfer failures achieve a clinical pregnancy. It may be an option if your infertility has no known cause and you meet the other study checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 40 years old
- You have infertility with no clear cause, or the cause is male or blocked fallopian tubes (tubal factor)
- You have had repeated embryo transfers (at least two or more transfers of 3 good-quality embryos) without a clinical pregnancy
- You have French health coverage (including AME, if applicable) and can sign consent
- You do not have specific medical causes of repeated failure, like certain immune or infection-related problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune-related blood patterns and other measurements to better understand why some women have repeated pregnancy loss or repeated IVF implantation failure. If you qualify, your answers and test results may help researchers identify biomarkers that could guide future care.
This study looks at the lining of the uterus (womb) in women who have had repeated IVF failures or miscarriages, to see if differences in the lining's germs or immune system might play a role. The goal is to find ways to improve future fertility treatments.
This trial tests whether a drug called thymosin-α1 can help women who have had two or more failed embryo transfers with genetically normal embryos. It aims to improve the chances of successful implantation.
This study looks at the lining of the womb in women who have had repeated failed embryo transfers, to understand why implantation may not happen. By taking a small sample of the womb lining, researchers hope to find clues that could improve future treatment.
This study tests whether checking the timing of your uterine lining (endometrium) before embryo transfer can help women who have had multiple failed IVF attempts. It may help doctors decide the best day to transfer an embryo to improve the chance of pregnancy.
This Phase 2 study tests whether certolizumab can improve pregnancy outcomes in people with antiphospholipid syndrome (APS). It targets pregnancy complications related to APS while closely checking safety, infections, and certain health conditions.
Hear when a new Recurrent Unexplained Implantation Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.